International Scientific Collaborators
Rehabilitation in Mutiple Sclerosis, a european network for best practice and research. EuRIMS represent and bring together health care professionals, researchers and patient organisations from different settings with the aim to enhance activity, participation and autonomy of people with MS.
Read more on the EuRIMS homepage.
An international case-control study of environmental risk factors in Multiple Sclerosis. The use of a common methodology to study MS etiology across several continents enhances the comparability of results in different geographic regions and research settings, reduces the resources required for study deisgn and enhances the opportunity for data harmonization.
For further information, the following article describes the methodology and design of the study:
A Randomized Autologous heMatopoietic stem cell transplantation study that compares HSCT to other high-efficacy treatment options for MS. The goal is to include 100 patients in the study. The RAM-MS study is run from Haukeland University Hospital, with three other study-centres in Norway: at St. Olavs Hospital in Trondheim, at Akershus University Hospital and at the University Hospital of Northern Norway in Tromsø. Internationally there is one study centre at Uppsala University Hospital in Sweden, one at Sahlgrenska University Hospital in Gothenburg, Sweden, another at Rigshospitalet in Copenhagen, Denmark and one located at Amsterdam UMC, the Netherlands.
Harvard T.H. Chan School of Public Health
The purpose of this research group is to identify causes, risk factors (positive and negative), and biomarkers of susceptibility and early diagnosis of multiple sclerosis (MS), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). The Norwegian MS Competence Centre and Research Group has a long standing cooperation with Professor Alberto Ascherio, MD, DrPH, and two former Ph.D.-Candidates from our research group, Marianna Cortese, MD, Ph.D., and Kjetil Lauvland Bjørnevik, MD, Ph.D., are currently working with prof. Ascherio at the Harvard T.H. Chan School of Public Health.
A Study of Mesenchymal stem cells as Regenerative Treatment for Multiple Sclerosis. The objective of this project is to investigate the potential of regenerative stem cell treatment with MSCs in MS and to increase the understanding of the underlying mechanisms action. The project involves collaboration with Prof. Dr.med Hubert Schrezenmeier at the Institute for Clinical Transfusion Medicine and Immunogenetics at Ulm University, Germany.